Results

Aldeyra Therapeutics Inc.

11/09/2021 | Press release | Distributed by Public on 11/09/2021 07:14

Aldeyra Therapeutics Announces Completion of Enrollment in Phase 3 TRANQUILITY Trial in Patients with Dry Eye Disease and Reiterates New Drug Application (NDA) Submission Guidance